TUCCI, MARCO GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 11.261
AS - Asia 4.590
EU - Europa 4.087
SA - Sud America 1.155
Continente sconosciuto - Info sul continente non disponibili 639
AF - Africa 196
OC - Oceania 10
Totale 21.938
Nazione #
US - Stati Uniti d'America 11.031
SG - Singapore 1.907
IT - Italia 1.438
CN - Cina 920
BR - Brasile 864
HK - Hong Kong 587
SE - Svezia 507
RU - Federazione Russa 448
DE - Germania 362
VN - Vietnam 323
FR - Francia 294
FI - Finlandia 270
GB - Regno Unito 219
UA - Ucraina 196
IN - India 160
BD - Bangladesh 125
CA - Canada 121
ID - Indonesia 111
AR - Argentina 97
IQ - Iraq 62
ZA - Sudafrica 54
PL - Polonia 52
NL - Olanda 50
MX - Messico 48
CO - Colombia 46
BE - Belgio 45
EC - Ecuador 45
PK - Pakistan 42
JP - Giappone 41
AT - Austria 40
CI - Costa d'Avorio 39
TR - Turchia 38
SA - Arabia Saudita 37
CL - Cile 36
PH - Filippine 35
ES - Italia 29
MY - Malesia 29
LT - Lituania 26
VE - Venezuela 26
MA - Marocco 24
IE - Irlanda 22
UZ - Uzbekistan 21
KE - Kenya 19
JO - Giordania 18
NP - Nepal 18
TN - Tunisia 17
PY - Paraguay 15
JM - Giamaica 14
CH - Svizzera 13
IR - Iran 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 11
AZ - Azerbaigian 10
KR - Corea 10
AL - Albania 9
HN - Honduras 9
KZ - Kazakistan 9
OM - Oman 9
PE - Perù 9
GR - Grecia 8
UY - Uruguay 8
AU - Australia 7
EG - Egitto 7
ET - Etiopia 7
GT - Guatemala 7
BO - Bolivia 6
IL - Israele 6
LB - Libano 6
TH - Thailandia 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
KG - Kirghizistan 5
LV - Lettonia 5
MK - Macedonia 5
PS - Palestinian Territory 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
HU - Ungheria 4
KW - Kuwait 4
SN - Senegal 4
AO - Angola 3
BH - Bahrain 3
DZ - Algeria 3
HR - Croazia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
IS - Islanda 2
LY - Libia 2
MD - Moldavia 2
Totale 21.260
Città #
Singapore 1.080
Ashburn 1.059
Fairfield 930
Chandler 700
San Jose 677
Woodbridge 635
Hong Kong 579
Milan 538
Jacksonville 432
Houston 425
Nyköping 407
Seattle 374
Cambridge 362
Beijing 318
Wilmington 302
Ann Arbor 269
Council Bluffs 243
Lauterbourg 176
New York 176
Helsinki 168
Dallas 157
Los Angeles 157
Lawrence 151
Roxbury 149
Rome 144
Nanjing 114
Santa Clara 109
Bari 99
Des Moines 99
Ho Chi Minh City 92
Boardman 84
São Paulo 82
Brooklyn 78
Princeton 78
Jakarta 77
Columbus 69
Falkenstein 67
Buffalo 65
Chicago 62
Hanoi 61
Inglewood 61
Munich 60
Figino 51
San Diego 48
Warsaw 47
Brussels 44
London 42
Nuremberg 41
Abidjan 39
Paris 36
Frankfurt am Main 35
Redwood City 33
Dong Ket 31
Montreal 31
Phoenix 31
Turin 29
Denver 28
Toronto 28
North Bergen 27
Tokyo 27
Shenyang 26
Rio de Janeiro 24
Chennai 23
Hebei 23
Nanchang 23
Orem 23
Dublin 22
Johannesburg 22
Naples 22
San Francisco 22
Stockholm 22
Atlanta 21
Baghdad 21
Mumbai 21
Dearborn 20
Salt Lake City 20
Belo Horizonte 19
Santiago 19
Tashkent 19
Amsterdam 18
Vienna 18
Dhaka 17
Moscow 17
Quito 17
Washington 17
New Delhi 16
Tianjin 16
Amman 15
Bologna 15
Curitiba 15
Guangzhou 15
Ottawa 15
Taranto 15
The Dalles 15
Brasília 14
Cape Town 14
Da Nang 14
Marseille 14
Mexico City 14
Porto Alegre 14
Totale 13.350
Nome #
Ruolo degli agonisti dei recettori sigma-2 nei fenomeni di farmacoresistenza associati alla chemioterapia nel mieloma multiplo 948
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 353
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study 242
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 217
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 200
Adenocarcinoma of the ceruminous glands: role of the VMAT 198
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine 198
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 197
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology 192
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 187
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 184
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 183
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 183
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 182
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 181
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 174
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 172
Avβ3 integrin: Pathogenetic role in osteotropic tumors 170
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 170
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 168
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 168
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 167
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 159
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 159
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 158
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 157
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 155
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis 152
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 152
The clonal heterogenicity of circulating tumor cells (CTCs) drives their metastatic potential: a new NOD‐SCID melanoma model 152
The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice 152
Cytotherapies in multiple myeloma: a complementary approach to current treatments 151
Strong association of a functional polymorphism in the monocyte chemoattractant protein 1 promoter gene with lupus nephritis 150
Anemia in multiple myeloma: role of deregulated plasma cell apoptosis 150
An update on Merkel cell carcinoma 147
Does cilengitide deserve another chance? 146
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? 145
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 144
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 144
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 143
A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. 139
Successful treatment with apremilast of severe psoriasis exacerbation during nivolumab therapy for metastatic melanoma 139
AlphaVBeta3+ (AvB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 137
Recent advances in understanding the pathogenesis of anemia in multiple myeloma 137
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 137
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 135
DLC-1 down-regulation via exosomal miR-106b-3p exchange promotes CRC metastasis by the epithelial-to-mesenchymal transition 134
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro 132
A functional polymorphism in the monocyte chemoattractant protein (MCP) - 1 promoter gene is strongly associated with lupus nephritis 131
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease 130
Alpha(V)Beta(3) (alpha(v)beta(3)) integrin drives the osteoclastogenesis through a osteoclast-like functional differentiation of myeloma cells 129
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 129
The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors. 129
Large extracellular vesicles—a new frontier of liquid biopsy in oncology 128
Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma 128
[Malignant neoplasms and AIDS. Review of the literature and critical considerations on a case of epidermoid carcinoma of the anus]. FT Neoplasie maligne e AIDS. Rassegna della letteratura e considerazioni critiche su un caso di carcinoma epidermoide dell'ano. 127
The day after mass COVID-19 vaccination: incidence of vaccine-related lymphadenopathy PET and impact on oncologic patients management 127
A new tool for the evaluation of disease activity in lupus nephritis: Urinary monocyte chemoattractant protein (MCP)-1. 126
Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus 126
Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer 125
Massive hyper-progression during anti-PD1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review 125
Severe anemia in a patient with vulvar melanoma 123
Negative regulation of erythroblast maturation by Fas-L+/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma 122
Antiphosphatidylserine antibodies in human immunodeficiency virus-1 patients with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 121
Nef protein induces differential effects in CD8+ cells from HIV-1-infected patients 121
Induction of apoptosis by the hydrocarbon oil pristane: Implications for pristane-induced lupus 121
miRNAs in melanoma: a defined role in tumor progression and metastasis 121
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer 120
A functional polymorphism in the monocyte chemoattractant protein (MCP)-1 promoter gene is strongly associated with lupus nephritis 120
A role for fas-ligand in the pathogenesis and progression of multiple myeloma(MM). 119
Antiphosphatidylserine antibodies in human immunodeficiency virus-1(+) patients correlate with evidence of T-cell apoptosis and mediate antibody-dependent cellular cytotoxicity 117
Erratum for Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 117
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients. 117
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 116
The immune escape in melanoma: role of the impaired dendritic cell function 114
Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation 114
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 114
Prognostic factors and current treatment strategies for renal cell carcinoma metastatic to the brain: An overview 114
Checkpoint Inhibitor-Induced Colitis: An Update 112
Is measurement of IL-10 useful for disease management in SLE? 112
Dendritic Cells and Malignant Plasma Cells: An Alliance in Multiple Myeloma Tumor Progression? 112
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice 110
Mast cells positive to c-kit receptor and to tryptase in normal to cancer pancreatic tissue and the correlation with angiogenesis. 110
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 109
Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey. 109
Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis 108
Alphavbeta3 (AVB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 107
Fas-L up-regulation by highly malignant myeloma plasma cells: role in the pathogenesis of anemia and disease progression 106
Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia 104
Immunomodulation of T and B cell functions in multiple myeloma patients treated with combined erythropoietin and α-interferon therapy 104
Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015 104
null 103
In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells 102
Increased IL-18 production by dendritic cells in active inflammatory myopathies 102
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 102
β3 integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells 102
Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia 101
Biliary tract cancers: moving from the present standards of care towards the use of immune checkpoint inhibitors 101
Non-Melanoma Skin Cancers: Biological and Clinical Features 101
L'eritropoietina umana nel trattamento dell'anemia associata al mieloma multiplo: potenziale effetto mitogeno sui linfociti B 99
Totale 14.831
Categoria #
all - tutte 92.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022906 0 0 16 57 55 80 37 53 75 83 193 257
2022/20231.888 284 222 124 159 193 253 37 231 297 17 45 26
2023/2024680 62 127 41 102 64 114 20 33 9 18 15 75
2024/20253.310 134 38 285 160 95 271 336 288 172 216 427 888
2025/20268.654 1.055 341 448 776 801 442 848 246 896 736 1.158 907
2026/20271.031 254 466 311 0 0 0 0 0 0 0 0 0
Totale 21.938